Acquired by Johnson & Johnson in December 2022
Company logo

ABMD - Abiomed, Inc.

NASDAQ -> Healthcare -> Medical Devices
Danvers, United States
Type: Equity

ABMD price evolution
ABMD
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Current assets
Cash $182.34 $180.49 $132.82 $144.25
Short term investments $638.04 $663.83 $625.79 $524.97
Net receivables $94.47 $91.1 $90.61 $88.95
Inventory $102.24 $95.37 $93.98 $90.2
Total current assets $1062.8 $1060.36 $976.47 $885.01
Long term investments $116.87 $159.88 $220.09 $262.63
Property, plant & equipment $195.16 $198.48 $202.49 $196.88
Goodwill & intangible assets $109.79 $113.02 $116.3 $117.73
Total noncurrent assets $633.75 $643.28 $696.92 $707.87
Total investments $754.91 $823.71 $845.88 $787.6
Total assets $1696.54 $1703.64 $1673.39 $1592.88
Current liabilities
Accounts payable $35.07 $34.8 $35.35 $32.07
Deferred revenue $25.96 $23.62 $26.36 $24.87
Short long term debt
Total current liabilities $134.06 $140.76 $138.46 $126.8
Long term debt
Total noncurrent liabilities $22.7 $26.68 $31.61 $33.14
Total debt
Total liabilities $156.76 $167.44 $170.07 $159.94
Shareholders' equity
Retained earnings $1125.2 $1019.07 $964.51 $904.19
Other shareholder equity -$46.65 -$38.27 -$27.16 -$20.49
Total shareholder equity $1539.79 $1536.2 $1503.33 $1432.94
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $132.82 $232.71 $192.34 $121.02
Short term investments $625.79 $350.99 $250.78 $370.68
Net receivables $90.61 $97.18 $84.65 $90.81
Inventory $93.98 $81.06 $90.09 $80.94
Total current assets $976.47 $787.97 $635.86 $677.2
Long term investments $220.09 $264.08 $207.79 $21.72
Property, plant & equipment $202.49 $197.13 $164.93 $145
Goodwill & intangible assets $116.3 $120.72 $31.97 $32.6
Total noncurrent assets $696.92 $706.39 $580.6 $377.15
Total investments $845.88 $615.07 $458.57 $392.39
Total assets $1673.39 $1494.36 $1216.46 $1054.35
Current liabilities
Accounts payable $35.35 $34.84 $32.77 $32.19
Deferred revenue $26.36 $24.32 $19.15 $16.39
Short long term debt
Total current liabilities $138.46 $128.97 $131.88 $106
Long term debt
Total noncurrent liabilities $31.61 $35.72 $19.11 $11.46
Total debt $12.22
Total liabilities $170.07 $164.68 $151 $117.46
Shareholders' equity
Retained earnings $964.51 $828.01 $602.48 $399.47
Other shareholder equity -$27.16 -$11.45 -$11.19 -$14.69
Total shareholder equity $1503.33 $1329.67 $1065.47 $936.89
(in millions $) 30 Oct 2022 30 Jun 2022 1 May 2022 31 Dec 2021
Revenue
Total revenue $277.15 $261.18
Cost of revenue $52.63 $47.63
Gross Profit $224.52 $213.55
Operating activities
Research & development $40.48 $40.87
Selling, general & administrative $118 $107.62
Total operating expenses $158.47 $148.98
Operating income $66.05 $64.57
Income from continuing operations
EBIT $69.82 $57.88
Income tax expense $15.27 $12.13
Interest expense
Net income
Net income $54.55 $45.75
Income (for common shares) $54.55 $45.75
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Revenue
Total revenue $1031.75 $847.52 $840.88 $769.43
Cost of revenue $188.16 $161.91 $151.31 $129.57
Gross Profit $843.6 $685.62 $689.58 $639.87
Operating activities
Research & development $163.4 $121.88 $98.76 $93.5
Selling, general & administrative $423.49 $334.18 $341.6 $321.55
Total operating expenses $702.88 $456.06 $440.36 $415.05
Operating income $140.72 $229.56 $249.22 $224.81
Income from continuing operations
EBIT $190.56 $288.22 $256.82 $263.36
Income tax expense $54.05 $62.7 $53.82 $4.34
Interest expense
Net income
Net income $136.5 $225.53 $203.01 $259.02
Income (for common shares) $136.5 $225.53 $203.01 $259.02
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Net income $106.13 $54.55 $60.33 $45.75
Operating activities
Depreciation $6.72 $6.62 $7.29 $6.93
Business acquisitions & disposals $39.99
Stock-based compensation $16.01 $13.36 $11.99 $12.38
Total cash flows from operations $13.42 $68.1 $78.97 $90.49
Investing activities
Capital expenditures -$5.61 -$6.78 -$14.89 -$6.48
Investments $67.18 $14.9 -$77.68 -$173.54
Total cash flows from investing $101.57 $8.11 -$92.57 -$180.02
Financing activities
Dividends paid
Sale and purchase of stock -$108.33 -$12.99 $4.88 $0.44
Net borrowings
Total cash flows from financing -$110.18 -$23.94 $4.75 -$6.16
Effect of exchange rate -$2.96 -$4.61 -$2.58 -$1.93
Change in cash and equivalents $1.84 $47.67 -$11.44 -$97.63
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income $136.5 $225.53 $203.01 $259.02
Operating activities
Depreciation $28.09 $24.1 $20.43 $14.12
Business acquisitions & disposals -$82.82 $15.7
Stock-based compensation $52.73 $47.01 $39.78 $54.49
Total cash flows from operations $285.39 $274.58 $314.92 $252.2
Investing activities
Capital expenditures -$35.76 -$53.38 -$44.01 -$44
Investments -$262.41 -$185.66 -$81.45 -$72.45
Total cash flows from investing -$380.99 -$223.34 -$125.45 -$116.45
Financing activities
Dividends paid
Sale and purchase of stock $16.66 $3.24 -$76.03 $16
Net borrowings
Total cash flows from financing -$2.2 -$8.07 -$117.72 -$55.77
Effect of exchange rate -$2.09 -$2.8 -$0.43 -$1.92
Change in cash and equivalents -$99.89 $40.37 $71.32 $78.05
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding 45.17M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 0.00
Book/Share 35.12
Cash/Share 4.04
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 0.11
Net debt/EBITDA N/A
Current ratio 7.93
Quick ratio 7.17